Horror FPS 'ILL' Gets Story Trailer, 2027 Release Window
Team Clout's debut marks a rare cross-medium collaboration between film and game horror talent, bringing the aesthetic of 'Longlegs' into an interactive format.
Reporting from 3 sources: GAME Watch (Impress), Denfaminicogamer, Game Spark.
During Sony's State of Play broadcast on June 3, 2026, the story trailer for the horror FPS 'ILL' was released. The game is the debut title from Team Clout, a studio formed by staff who worked on the horror film 'Longlegs' and the game 'Until Dawn'. The trailer shows the injured protagonist being brought into a hospital, along with other characters and fragments of the story. It also reveals weapons such as a revolver, shotgun, submachine gun, and knife. The game is a survival action horror title set in a massive research facility, where players fight grotesque creatures from a first-person perspective. 'ILL' is scheduled for release in 2027 on PS5, Xbox Series X|S, and Steam.
The trailer was released during Sony Interactive Entertainment's "State of Play" stream on June 3, 2026. The developer Mundfish, known for the Atomic Heart series, is publishing the game. Team Clout is a new studio that includes staff who worked on the horror film Longlegs and the game Until Dawn, making ILL their debut title.
The trailer shows the injured protagonist being brought into a hospital. It also shows other characters and fragments of the story. The weapons shown include a revolver, shotgun, submachine gun, and knife. The game is a survival action horror title set in a massive research facility, where players fight grotesque creatures from a first-person perspective. The trailer depicts scenes of battling various creatures, including a giant creature and one that clings to the player's arm even when only its head remains.
ILL is scheduled for release in 2027 on PS5, Xbox Series X|S, and Steam.
Synthesized by Yomimono from the 3 cited sources below, including Japanese-language reporting where cited, then editorially reviewed before publishing.